DXCM logo

DexCom (DXCM) EBITDA

Annual EBITDA

$916.70 M
+$351.40 M+62.16%

December 31, 2023


Summary


Performance

DXCM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDXCMprofitabilitymetrics:

Quarterly EBITDA

$237.40 M
-$7.30 M-2.98%

September 30, 2024


Summary


Performance

DXCM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDXCMprofitabilitymetrics:

TTM EBITDA

$975.30 M
-$56.10 M-5.44%

September 30, 2024


Summary


Performance

DXCM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDXCMprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

DXCM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+62.2%-3.0%-5.4%
3 y3 years+143.3%+114.5%+63.0%
5 y5 years+1327.2%+114.5%+63.0%

DXCM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+142.8%-21.8%+458.6%-5.4%+157.6%
5 y5-yearat high+330.0%-21.8%+458.6%-5.4%+357.5%
alltimeall timeat high+1327.2%-21.8%+248.3%-5.4%+1219.8%

DexCom EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$237.40 M(-3.0%)
$975.30 M(-5.4%)
Jun 2024
-
$244.70 M(+29.1%)
$1.03 B(+3.6%)
Mar 2024
-
$189.60 M(-37.5%)
$995.60 M(+8.6%)
Dec 2023
$916.70 M(+62.2%)
$303.60 M(+3.4%)
$916.70 M(+16.4%)
Sep 2023
-
$293.50 M(+40.5%)
$787.30 M(+15.1%)
Jun 2023
-
$208.90 M(+88.7%)
$683.80 M(+14.3%)
Mar 2023
-
$110.70 M(-36.5%)
$598.50 M(+5.7%)
Dec 2022
$565.30 M(+49.7%)
$174.20 M(-8.3%)
$566.10 M(+30.3%)
Sep 2022
-
$190.00 M(+53.7%)
$434.40 M(+11.9%)
Jun 2022
-
$123.60 M(+57.9%)
$388.20 M(-0.5%)
Mar 2022
-
$78.30 M(+84.2%)
$390.00 M(+3.0%)
Dec 2021
$377.60 M(+0.2%)
$42.50 M(-70.4%)
$378.60 M(-18.1%)
Sep 2021
-
$143.80 M(+14.7%)
$462.40 M(+5.9%)
Jun 2021
-
$125.40 M(+87.4%)
$436.50 M(+11.1%)
Mar 2021
-
$66.90 M(-47.0%)
$392.90 M(+4.3%)
Dec 2020
$376.80 M(+76.7%)
$126.30 M(+7.1%)
$376.80 M(+0.6%)
Sep 2020
-
$117.90 M(+44.1%)
$374.40 M(+13.4%)
Jun 2020
-
$81.80 M(+61.0%)
$330.30 M(+24.3%)
Mar 2020
-
$50.80 M(-59.0%)
$265.80 M(+24.7%)
Dec 2019
$213.20 M(-385.4%)
$123.90 M(+67.9%)
$213.20 M(-401.1%)
Sep 2019
-
$73.80 M(+326.6%)
-$70.80 M(-18.7%)
Jun 2019
-
$17.30 M(-1061.1%)
-$87.10 M(+37.6%)
Mar 2019
-
-$1.80 M(-98.9%)
-$63.30 M(-15.3%)
Dec 2018
-$74.70 M(+279.2%)
-$160.10 M(-378.4%)
-$74.70 M(-172.6%)
Sep 2018
-
$57.50 M(+39.9%)
$102.90 M(+99.0%)
Jun 2018
-
$41.10 M(-411.4%)
$51.70 M(+1515.6%)
Mar 2018
-
-$13.20 M(-175.4%)
$3.20 M(-116.2%)
Dec 2017
-$19.70 M(-60.0%)
$17.50 M(+177.8%)
-$19.70 M(-51.1%)
Sep 2017
-
$6.30 M(-185.1%)
-$40.30 M(-33.8%)
Jun 2017
-
-$7.40 M(-79.5%)
-$60.90 M(-12.5%)
Mar 2017
-
-$36.10 M(+1064.5%)
-$69.60 M(+41.5%)
Dec 2016
-$49.20 M(+6.3%)
-$3.10 M(-78.3%)
-$49.20 M(+18.8%)
Sep 2016
-
-$14.30 M(-11.2%)
-$41.40 M(-38.0%)
Jun 2016
-
-$16.10 M(+2.5%)
-$66.80 M(+29.2%)
Mar 2016
-
-$15.70 M(-434.0%)
-$51.70 M(+11.7%)
Dec 2015
-$46.30 M(+253.4%)
$4.70 M(-111.8%)
-$46.30 M(-1.5%)
Sep 2015
-
-$39.70 M(+3870.0%)
-$47.00 M(+365.3%)
Jun 2015
-
-$1.00 M(-90.3%)
-$10.10 M(-22.3%)
Mar 2015
-
-$10.30 M(-357.5%)
-$13.00 M(-0.8%)
Dec 2014
-$13.10 M
$4.00 M(-242.9%)
-$13.10 M(-25.1%)
Sep 2014
-
-$2.80 M(-28.2%)
-$17.50 M(-6.9%)
Jun 2014
-
-$3.90 M(-62.5%)
-$18.80 M(-19.0%)
DateAnnualQuarterlyTTM
Mar 2014
-
-$10.40 M(+2500.0%)
-$23.20 M(+5.9%)
Dec 2013
-$21.90 M(-55.3%)
-$400.00 K(-90.2%)
-$21.90 M(-21.8%)
Sep 2013
-
-$4.10 M(-50.6%)
-$28.00 M(-28.4%)
Jun 2013
-
-$8.30 M(-8.8%)
-$39.10 M(-11.1%)
Mar 2013
-
-$9.10 M(+40.0%)
-$44.00 M(-10.4%)
Dec 2012
-$49.00 M(+19.8%)
-$6.50 M(-57.2%)
-$49.10 M(-8.6%)
Sep 2012
-
-$15.20 M(+15.2%)
-$53.71 M(+5.8%)
Jun 2012
-
-$13.20 M(-7.0%)
-$50.79 M(+15.3%)
Mar 2012
-
-$14.20 M(+27.8%)
-$44.06 M(+7.7%)
Dec 2011
-$40.90 M(-20.3%)
-$11.11 M(-9.5%)
-$40.90 M(+4.9%)
Sep 2011
-
-$12.28 M(+89.7%)
-$38.99 M(-1.1%)
Jun 2011
-
-$6.47 M(-41.4%)
-$39.43 M(-10.1%)
Mar 2011
-
-$11.04 M(+20.0%)
-$43.86 M(-14.5%)
Dec 2010
-$51.30 M(+19.0%)
-$9.20 M(-27.7%)
-$51.30 M(+0.5%)
Sep 2010
-
-$12.73 M(+16.7%)
-$51.06 M(+3.7%)
Jun 2010
-
-$10.90 M(-41.0%)
-$49.23 M(-3.5%)
Mar 2010
-
-$18.47 M(+106.2%)
-$51.02 M(+18.4%)
Dec 2009
-$43.11 M(-13.4%)
-$8.96 M(-17.8%)
-$43.11 M(-7.4%)
Sep 2009
-
-$10.90 M(-14.1%)
-$46.53 M(-4.6%)
Jun 2009
-
-$12.69 M(+20.1%)
-$48.77 M(+0.1%)
Mar 2009
-
-$10.56 M(-14.7%)
-$48.70 M(-2.2%)
Dec 2008
-$49.79 M(+14.9%)
-$12.38 M(-5.8%)
-$49.79 M(+2.8%)
Sep 2008
-
-$13.14 M(+4.2%)
-$48.44 M(+5.2%)
Jun 2008
-
-$12.62 M(+8.3%)
-$46.03 M(+4.2%)
Mar 2008
-
-$11.65 M(+5.6%)
-$44.16 M(+1.9%)
Dec 2007
-$43.34 M(-7.0%)
-$11.03 M(+2.8%)
-$43.34 M(+0.8%)
Sep 2007
-
-$10.73 M(-0.2%)
-$43.00 M(-6.4%)
Jun 2007
-
-$10.75 M(-0.7%)
-$45.92 M(-2.5%)
Mar 2007
-
-$10.83 M(+1.3%)
-$47.08 M(+2.6%)
Dec 2006
-$46.62 M(+48.6%)
-$10.69 M(-21.8%)
-$45.88 M(-3.2%)
Sep 2006
-
-$13.66 M(+14.7%)
-$47.40 M(+16.7%)
Jun 2006
-
-$11.90 M(+23.6%)
-$40.60 M(+16.2%)
Mar 2006
-
-$9.63 M(-21.1%)
-$34.93 M(+13.8%)
Dec 2005
-$31.36 M(+131.0%)
-$12.20 M(+77.9%)
-$30.69 M(+66.0%)
Sep 2005
-
-$6.86 M(+10.1%)
-$18.49 M(+59.0%)
Jun 2005
-
-$6.23 M(+15.6%)
-$11.62 M(+115.6%)
Mar 2005
-
-$5.39 M
-$5.39 M
Dec 2004
-$13.58 M(+38.1%)
-
-
Dec 2003
-$9.83 M(+55.8%)
-
-
Dec 2002
-$6.31 M(-6.1%)
-
-
Dec 2001
-$6.72 M(+67.5%)
-
-
Dec 2000
-$4.01 M
-
-

FAQ

  • What is DexCom annual EBITDA?
  • What is the all time high annual EBITDA for DexCom?
  • What is DexCom annual EBITDA year-on-year change?
  • What is DexCom quarterly EBITDA?
  • What is the all time high quarterly EBITDA for DexCom?
  • What is DexCom quarterly EBITDA year-on-year change?
  • What is DexCom TTM EBITDA?
  • What is the all time high TTM EBITDA for DexCom?
  • What is DexCom TTM EBITDA year-on-year change?

What is DexCom annual EBITDA?

The current annual EBITDA of DXCM is $916.70 M

What is the all time high annual EBITDA for DexCom?

DexCom all-time high annual EBITDA is $916.70 M

What is DexCom annual EBITDA year-on-year change?

Over the past year, DXCM annual EBITDA has changed by +$351.40 M (+62.16%)

What is DexCom quarterly EBITDA?

The current quarterly EBITDA of DXCM is $237.40 M

What is the all time high quarterly EBITDA for DexCom?

DexCom all-time high quarterly EBITDA is $303.60 M

What is DexCom quarterly EBITDA year-on-year change?

Over the past year, DXCM quarterly EBITDA has changed by -$7.30 M (-2.98%)

What is DexCom TTM EBITDA?

The current TTM EBITDA of DXCM is $975.30 M

What is the all time high TTM EBITDA for DexCom?

DexCom all-time high TTM EBITDA is $1.03 B

What is DexCom TTM EBITDA year-on-year change?

Over the past year, DXCM TTM EBITDA has changed by -$56.10 M (-5.44%)